The evaluation of Remdesivir Utilization pattern and its correlation with clinical indicators in hospitalized patients during COVID
Background: In 2019 COVID became the cause of a pandemic, with approximately 500,000 deaths in six months worldwide. Remdesivir, the first drug approved by the U.S. Food and Drug Administration (FDA) for COVID-19 treatment, gained attention from numerous medical centers worldwide. Objective:The...
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Research Center for Rational Use of Drugs (RCRUD)
2023-12-01
|
| Serie: | Journal of Pharmaceutical Care |
| Ämnen: | |
| Länkar: | https://jpc.tums.ac.ir/index.php/jpc/article/view/596 |